ISSN (Print):
2212-697X
ISSN (Online):
2212-6988
Download PDF Flyer

Clinical Cancer Drugs

Limited Time Complementary OA Offer Papers submitted on or before April 30, 2024, will be published as Promotional Open Access

Volume 10 , 2024

Back Journal Home

Institutional Members
Topic(s) Covered

1 Topic(s)

View
Covered Disease(s)

1 Disease(s)

View

Aims & Scope

Clinical Cancer Drugs publishes original research and (as well as) expert reviews, and thematic issues in all core areas of translational and clinical cancer drug research.

The journal publishes pre-clinical and clinical studies on the development of new anti-cancer agents. Clinical studies of new reported anti-cancer drugs include Phase 1–IV clinical trial studies, their designs, research methodologies, and analyses. The journal is essential reading to clinical oncologists, toxicologists, medicinal chemists, and to pharmacologists.

Special Offers

30% discount on the single-issue cost to authors on the purchase of issue(s) in which their article is published.
Multiple issue copies at discounted rates.

Archived in
Announcements
© 2024 Bentham Science Publishers | Privacy Policy